Posts by: Alice Melão

Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective compared to DMARD combination in ... Read more

May 23, 2017May 23, 2017

Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

News, rheumatoid arthritis

Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis (RA) who have not responded ... Read more

May 19, 2017May 19, 2017

Potential Treatment Sirukumab Up Before FDA and EMA with High Expectations, J&J Reports

News, rheumatoid arthritis

A potential treatment for moderate-to-severe rheumatoid arthritis, sirukumab, is under consideration by the U.S. Food and Drug Administration for approval, with the application supported by results from five Phase 3 clinical trials. ... Read more

May 12, 2017September 22, 2017

Researchers Uncover Gene Variations Linked to RA, Other Immune Diseases

News, rheumatoid arthritis

A large-scale genetic study, in combination with information from electronic health records (EHRs), identified new human leukocyte antigen (HLA) associations with several immune conditions, including rheumatoid arthritis and multiple sclerosis. ... Read more

May 8, 2017May 10, 2017

Despite Treatment, 80% of RA Patients Report ‘Life-Altering’ Pain Weekly or Even Daily, Survey Finds

News

Honestly RA, an online survey for Americans with rheumatoid arthritis (RA), found that although most RA patients agree that the treatments improve their lives, 80 percent still experience life-altering pain multiple times ... Read more

November 21, 2016November 21, 2016

Therapy for Autoimmune Diseases Like RA Shows Positive Results in Clinical Trial

News

Phase 1 trial results of an investigative selective inhibitor drug demonstrated that single or multiple oral doses of the therapy are safe and well tolerated by healthy subjects. These results ... Read more

November 16, 2016November 19, 2016

Baricitinib’s Effectiveness in Treating RA Symptoms Supported in New Analyses of Phase 3 Trials

News

New data analyses of two Phase 3 clinical trials evaluating the investigational therapy baricitinib for the treatment of rheumatoid arthritis (RA) symptoms have revealed promising results compared to conventional synthetic ... Read more